Document Detail


In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.
MedLine Citation:
PMID:  11500258     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Novel polyoxyethylene esters of ketoprofen (1(a-e)), naproxen (2(a-e)) and diclofenac (3(a-e)) were synthesized and evaluated as potential dermal prodrugs of naproxen, ketoprofen and diclofenac. These esters were obtained by coupling these drugs with polyoxyethylene glycols by a succinic acid spacer. The aqueous solubilities, lipophilicities and hydrolysis rates of esters 1(a-e), 2(a-e) and 3(a-e) were determined in a buffered solution and in porcine esterase. The permeation of these prodrugs through excised human skin was studied in vitro. Furthermore we investigated the in vivo topical anti-inflammatory activity of esters 1(d), 2(e) and 3(e), which showed the best in vitro profile, evaluating the ability of these compounds to inhibit methyl nicotinate (MN)-induced skin erythema on healthy human volunteers. Esters 1(a-e), 2(a-e) and 3(a-e) showed good water stability and rapid enzymatic cleavage and their hydrolysis rates, both chemical and enzymatic, were not significantly affected by the length of the polyoxyethylenic chain used as promoiety. Concerning in vitro percutaneous absorption studies, only esters 1(d-e), 2(d-e) and 3(c-e) showed an increased flux through stratum corneum and epidermis membranes compared to their respective parent drugs. In vivo results showed an interesting delayed and sustained activity of esters 1(d) and 3(e) compared to the parent drugs. In conclusion polyoxyethylene glycols could prove to be suitable promoieties for ketoprofen, naproxen and diclofenac design since esters 1(d-e), 2(d-e) and 3(c-e) showed some requirements (chemical stability, enzymatic lability and an increased skin permeation) needed to obtain successful dermal prodrugs. Furthermore, was observed an appreciable and sustained in vivo topical anti-inflammatory activity of esters 1(d) and 3(e), compared to the parent drugs, using MN-induced erythema in human volunteers as inflammation model.
Authors:
F P Bonina; C Puglia; T Barbuzzi; P de Caprariis; F Palagiano; M G Rimoli; A Saija
Related Documents :
11497348 - Topical and transdermal delivery of antisense oligonucleotides.
10884938 - Visualization of percutaneous 3h-estradiol and 3h-norethindrone acetate transport acros...
15202928 - Penetration enhancement of transdermal delivery--current permutations and limitations.
21698598 - Influence of drug transport proteins on the pharmacokinetics and drug interactions of h...
2330938 - A social bonding-drug progression model of amphetamine use among young women.
16380358 - Grape fruit juice-drug interactions.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences     Volume:  14     ISSN:  0928-0987     ISO Abbreviation:  Eur J Pharm Sci     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-08-13     Completed Date:  2001-12-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9317982     Medline TA:  Eur J Pharm Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  123-34     Citation Subset:  IM    
Affiliation:
Department of Pharmaceutical Sciences, School of Pharmacy, University of Catania, Viale A. Doria 6, 95125 Catania, Italy. boninaf@mbox.unict.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Adult
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*,  chemistry,  metabolism
Area Under Curve
Diclofenac / administration & dosage,  chemistry,  metabolism
Erythema / drug therapy
Female
Gels
Humans
Ketoprofen / administration & dosage,  chemistry,  metabolism
Male
Middle Aged
Naproxen / administration & dosage,  chemistry,  metabolism
Polyethylene Glycols / administration & dosage*,  chemistry,  metabolism
Prodrugs / administration & dosage*,  chemistry,  metabolism
Skin Absorption / drug effects*,  physiology
Solubility
Solvents / administration & dosage,  chemistry,  metabolism
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Gels; 0/Polyethylene Glycols; 0/Prodrugs; 0/Solvents; 15307-86-5/Diclofenac; 22071-15-4/Ketoprofen; 22204-53-1/Naproxen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of c...
Next Document:  Effects of physical properties of powder particles on binder liquid requirement and agglomerate grow...